Insight Molecular Diagnostics Inc. (IMDX)

Sentiment-Signal

26,2

Bearisch

Composite Score (0–100)

Insider (25%)

35.5

1 Insider, 5,7M $ Volumen

Institutionell (22,5%)

Keine neuen Positionen

Aktivist (12,5%)

Kein 13D/13G

Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)

Score-Verlauf (90 Tage)

Stammdaten

OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing, assay design and development, and clinical trial support services, as well as various biomarker tests for pharmaceutical companies. The company has a collaboration agreement with Life Technologies Corporation to develop and collaborate in the commercialization of Oncomine Comprehensive Assay Plus and Determa IO assay for use with Ion Torrent Genexus integrated sequencer and purification system. OncoCyte Corporation was incorporated in 2009 and is based in Irvine, California.

Unternehmen & Branche

Name	Insight Molecular Diagnostics Inc.
Ticker	IMDX
CIK	0001642380
Boerse	US
Sektor	Healthcare
Industrie	Biotechnology
SIC	2835 · In Vitro & In Vivo Diagnostic Substances

Wertpapier & Kennzahlen

CUSIP	–
ISIN	–
Typ	Common Stock
Marktkapitalisierung	113,9 Mio. USD
Beta	1,53
Dividendenrendite	0,00 %

Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »

Finanzkennzahlen (SEC XBRL)

Periode	Filing	Umsatz	Nettoergebnis	EPS	Aktiva	Eigenkapital
2025-12-31	10-K	4,055,000	-50,222,000	-1.65	25,756,000	-31,464,000
2025-09-30	10-Q	260,000	-10,854,000	-0.34	43,937,000	-9,196,000
2025-06-30	10-Q	518,000	-9,742,000	-0.30	50,517,000	1,098,000
2025-03-31	10-Q	2,138,000	-6,671,000	-0.26	60,360,000	10,218,000
2024-12-31	10-K	1,881,000	-60,663,000	-4.66	35,081,000	-12,274,000
2024-09-30	10-Q	115,000	-13,493,000	-0.98	70,216,000	9,711,000
2024-06-30	10-Q	104,000	-4,530,000	-0.36	74,720,000	22,703,000
2024-03-31	10-Q	176,000	-9,129,000	-1.13	70,973,000	11,588,000
2023-12-31	10-K	1,503,000	-27,781,000	-3.75	74,892,000	20,468,000
2023-09-30	10-Q	429,000	-6,489,000	-0.81	81,587,000	36,143,000
2023-06-30	10-Q	463,000	-8,333,000	-1.07	87,540,000	43,600,000
2023-03-31	10-Q	297,000	3,033,000	0.40	82,800,000	37,933,000
2022-12-31	10-K	958,000	-72,902,000	-13.25	100,091,000	34,292,000
2022-09-30	10-Q	67,000	-9,333,000	-1.62	157,344,000	76,857,000
2022-06-30	10-Q	237,000	-8,300,000	-1.48	171,051,000	83,243,000
2022-03-31	10-Q	380,000	-10,291,000	-0.11	146,273,000	56,967,000
2021-12-31	10-K	3,589,000	-35,885,000		159,563,000	65,217,000
2021-09-30	10-K	984,000	-13,800,000
2021-09-30	10-Q	984,000	-13,800,000		168,341,000	99,349,000
2021-06-30	10-K	2,030,000	-10,493,000

Fondsaktivität (Vorquartalsvergleich)

Keine Fondsdaten für dieses Unternehmen vorhanden.

Insider-Transaktionen (12 Monate)

Datum	Insider	Rolle	Typ	Stückzahl	Kurs	Wert (USD)	Δ
2026-04-27	BROADWOOD PARTNERS, L.P.	10% Owner	Open Market Purchase	250,923	3.64	913,133.89	+224,9%
2026-04-27	BROADWOOD PARTNERS, L.P.	10% Owner	Open Market Purchase	0	0.00	0.00	0,0%
2026-04-24	BROADWOOD PARTNERS, L.P.	10% Owner	Open Market Purchase	38,880	3.53	137,083.10	+33,8%
2026-04-24	BROADWOOD PARTNERS, L.P.	10% Owner	Open Market Purchase	0	0.00	0.00	0,0%
2026-04-23	BROADWOOD PARTNERS, L.P.	10% Owner	Open Market Purchase	0	0.00	0.00	0,0%
2026-04-23	BROADWOOD PARTNERS, L.P.	10% Owner	Open Market Purchase	280,381	3.50	982,034.45	+241,8%
2026-04-20	BROADWOOD PARTNERS, L.P.	10% Owner	Open Market Purchase	40,690	3.88	157,966.72	+38,9%
2026-04-20	BROADWOOD PARTNERS, L.P.	10% Owner	Open Market Purchase	0	0.00	0.00	0,0%
2026-04-17	BROADWOOD PARTNERS, L.P.	10% Owner	Open Market Purchase	40,114	3.57	143,251.11	+35,3%
2026-04-17	BROADWOOD PARTNERS, L.P.	10% Owner	Open Market Purchase	0	0.00	0.00	0,0%
2026-04-16	BROADWOOD PARTNERS, L.P.	10% Owner	Open Market Purchase	102,057	3.45	351,657.80	+86,6%
2026-04-16	BROADWOOD PARTNERS, L.P.	10% Owner	Open Market Purchase	0	0.00	0.00	0,0%
2026-02-10	BROADWOOD PARTNERS, L.P.	10% Owner	Open Market Purchase	0	0.00	0.00	0,0%
2026-02-10	BROADWOOD PARTNERS, L.P.	10% Owner	Open Market Purchase	521,739	5.75	2,999,999.25	+738,8%

Top-Fondshalter

Keine Fondsdaten zu dieser Aktie vorhanden.